Bicara Therapeutics Statistics
Total Valuation
BCAX has a market cap or net worth of $1.40 billion. The enterprise value is $1.56 billion.
Important Dates
The next estimated earnings date is Saturday, November 16, 2024, before market open.
| Earnings Date | Nov 16, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BCAX has 54.39 million shares outstanding.
| Shares Outstanding | 54.39M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +26.05% |
| Owned by Insiders (%) | 7.17% |
| Owned by Institutions (%) | 11.80% |
| Float | 34.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.83, with a Debt / Equity ratio of 0.00.
| Current Ratio | 12.83 |
| Quick Ratio | 12.69 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.03M |
| Employee Count | 32 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BCAX has paid $6,000 in taxes.
| Income Tax | 6,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 887,284 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -58.34M |
| Pretax Income | -64.84M |
| Net Income | -64.84M |
| EBITDA | -58.30M |
| EBIT | -58.34M |
| Earnings Per Share (EPS) | -$93.43 |
Full Income StatementBalance Sheet
The company has $203.86 million in cash and $517,000 in debt, giving a net cash position of $203.34 million or $3.74 per share.
| Cash & Cash Equivalents | 203.86M |
| Total Debt | 517,000 |
| Net Cash | 203.34M |
| Net Cash Per Share | $3.74 |
| Equity (Book Value) | 192.50M |
| Book Value Per Share | -5.10 |
| Working Capital | 190.01M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$46.06 million and capital expenditures -$609,000, giving a free cash flow of -$46.67 million.
| Operating Cash Flow | -46.06M |
| Capital Expenditures | -609,000 |
| Free Cash Flow | -46.67M |
| FCF Per Share | -$0.86 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |